NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
CNTX Context Therapeutics
- 1.0200
- -0.0700-6.42%
Close Dec 20 16:00 ET
- 1.0600
- +0.0400+3.92%
Post 16:56 ET
76.50MMarket Cap-1.16P/E (TTM)
1.1136High0.9606Low339.73KVolume1.0600Open1.0900Pre Close342.64KTurnover0.87%Turnover RatioLossP/E (Static)75.00MShares2.750052wk High0.91P/B39.73MFloat Cap0.890052wk Low--Dividend TTM38.95MShs Float10.8700Historical High--Div YieldTTM14.04%Amplitude0.4700Historical Low1.0080Avg Price1Lot Size
Context Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 5, 2024
The average Context Therapeutics stock price target is 7.13 with a max estimate of 10.00 and a min estimate of 4.50
Review Context Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 5, 2024